KYMR
Kymera Therapeutics, Inc. · Healthcare
Director Bruce Booth sold $8.7M of Kymera Therapeutics, Inc.
Sold$8,735,143
$30.26Price
288,702Shares
−22%Stake
What KYMR did after the filing
- The stock from Wed, Nov 2 open, $29.52
- −5.5%
- S&P 500, same days
- +1.5%
Measured over 30 trading days, to the Dec 15 close.
Traded Fri, Oct 28. Filed Tue, Nov 1, 7:36 PM ET, after the close. Returns use the Nov 2 open and the Dec 15 close. Not investment advice.